Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback